Arab Press

بالشعب و للشعب
Saturday, Jul 12, 2025

NFT of mRNA vaccine research to go on sale

NFT of mRNA vaccine research to go on sale

A new NFT digital asset from the University of Pennsylvania showcases pivotal mRNA research that could lead to life-changing vaccines for COVID-19 and beyond.
Dr. Drew Weissman, a physician and immunologist known for his groundbreaking contributions to RNA biology, and the RNA biochemist Dr. Katalin Kariko developed the modified RNA technology that became a foundational component of BioNTech/Pfizer and Moderna’s mRNA vaccines for COVID-19.

Now, 18 months later, “Vaccines for a New Era,” the University of Pennsylvania mRNA NFT — non-fungible token — will be released on July 15, a Christie’s press release said.

The digital asset includes a 3D model of the critical technologies that have enabled mRNA vaccines as well as research focused on the discovery and development of mRNA therapeutics for some of the world’s most deadly diseases.

The NFT also features a dynamic video that shows how mRNA-based COVID-19 vaccines work, including how the mRNA vaccine enters the body’s cells and stimulates an immune response.

The animated digital art demonstrates mRNA encoding of the SAR-CoV-2 spike protein encapsulated inside lipid nanoparticles and administered as a vaccine, providing protection from the SARS-CoV-2 virus that causes COVID-19 disease.

The NFT also includes an explainer, image copies of Penn-owned mRNA patent documents, and an original letter from Dr. Weissman.

The proceeds from the sale of the NFT will be used to further important research at Penn.

While much of the attention focused on how quickly COVID-19 vaccines were developed in response to the pandemic, Dr. Weissman said that it resulted from a career’s worth of research and dedication by him and many other scientists worldwide.

“I laugh because it’s a 25-year overnight success,” Dr. Weissman said.

Initially, he and Dr. Kariko struggled to secure funding for their critical research.

“‘It took over 10 years to get people to recognize the potential of modified mRNA technology for therapeutic and vaccine development,” he said. “But Kati and I weren’t just sitting in a room hoping; we never gave up. The data looked very promising. The feeling that it would someday work and be a useful technology in creating new therapies kept us going.”

Dr. Kariko and Dr. Weissman together discovered how to modify mRNA to significantly reduce its inherent inflammatory activity.

Dr. Weissman’s lab later developed a delivery technique to package the mRNA in fat droplets known as lipid nanoparticles. These advances contributed to mRNA becoming safer, more effective and more practical for use in vaccines.

When the DNA sequence for the coronavirus was released on Jan. 10, 2020, vaccine developers immediately began to use Dr. Weissman and Dr. Kariko’s modified mRNA technology.

“When we saw that it was a coronavirus, we knew it was the spike protein that would be targeted in a vaccine,” Dr. Weissman said.

The first modified mRNA vaccine for COVID-19 developed by BioNTech and Pfizer, which was initially found to prevent severe disease and death with exceptional efficacy, was an important milestone.

“As a physician, my career aim has always been to contribute to development of technologies and products that help people,” Dr. Weissman said. “So seeing these extremely positive results of the Phase 3 human trials for modified mRNA vaccines against SAR-CoV-2 was an incredible feeling,” he said.

“Art is really important in communicating scientific ideas to the public. It’s a way to introduce people to science, how it works, why it’s so exciting, and its future potential. The COVID-19 vaccine is just one of many potential future products that may benefit from the modified mRNA technology developed at Penn.”

Dr. Weissman and his colleagues are developing a variety of potential future vaccines and therapies, such as a pan-coronavirus vaccine to prevent future pandemics, a universal flu vaccine, as well as vaccines to prevent herpes and malaria, among others.

Dr. Weissman also highlighted the possibility of using mRNA in vaccines to prevent fatal allergies and for gene therapies to treat sickle cell anemia.

The sale of the University of Pennsylvania mRNA NFT: Vaccines for a New Era will run exclusively online from July 15-25.
Newsletter

Related Articles

Arab Press
0:00
0:00
Close
Kurdistan Workers Party Takes Symbolic Step Towards Peace in Northern Iraq
BRICS Expands Membership with Indonesia and Ten New Partner Countries
Elon Musk Founds a Party Following a Poll on X: "You Wanted It – You Got It!"
AI Raises Alarms Over Long-Term Job Security
Russia Formally Recognizes Taliban Government in Afghanistan
Saudi Arabia Maintains Ties with Iran Despite Israel Conflict
Mediators Edge Closer to Israel-Hamas Ceasefire Agreement
Germany Seeks Taliban Deal to Deport Afghan Migrants
Emirates Airline Expands Market Share with New $20 Million Campaign
Robots Compete in Football Tournament in China Amid Injuries
China Unveils Miniature Insect-Like Surveillance Drone
Marc Marquez Claims Victory at Dutch Grand Prix Amidst Family Misfortune
Iran Executes Alleged Israeli Spies and Arrests Hundreds Amid Post-War Crackdown
Trump Asserts Readiness for Further Strikes on Iran Amid Nuclear Tensions
Qatar Airways Clears Backlog of Passengers Following Missile Threats
Iran's Parliament Votes to Suspend Cooperation with Nuclear Watchdog
Trump Announces Upcoming US-Iran Meeting Amid Controversial Airstrikes
Trump Moves to Reshape Middle East Following Israel-Iran Conflict
NATO Leaders Endorse Plan for Increased Defence Spending
U.S. Crude Oil Prices Drop Below $65 Amid Market Volatility
“You Have 12 Hours to Flee”: Israeli Threat Campaign Targets Surviving Iranian Officials
Oman Set to Introduce Personal Income Tax, First in Gulf
Germany and Italy Under Pressure to Repatriate $245bn of Gold from US Vaults
Trump Praises Iran’s ‘Very Weak’ Response After U.S. Strikes and Presses Israel to Pursue Peace
WATCH: Israeli forces show the aftermath of a massive airstrike at Iran's Isfahan nuclear site
We have new information and breaking details to share about what is shaping up to be a historic air campaign tonight
Six Massive Bombs Dropped on Fordow; Trump: 'A Historic Moment for the U.S., Israel, and the World'
Fordow: Deeply Buried Iranian Enrichment Site in U.S.–Israel Crosshairs
United States Conducts Precision Strikes on Iran’s Nuclear Sites
US strikes Iran nuclear sites, Trump says
Pakistan to nominate Trump for Nobel Peace Prize.
Israel Confirms Assassination of Quds Force Commander in Tehran
16 Billion Login Credentials Leaked in Unprecedented Cybersecurity Breach
Senate hearing on who was 'really running' Biden White House kicks off
G7 Leaders Fail to Reach Consensus on Key Global Issues
Mass exodus in Tehran as millions try to flee following Trump’s evacuation order
Iranian Military Officers Reportedly Seek Contact with Reza Pahlavi, Signal Intent to Defect
China's Iranian Oil Imports Face Disruption Amid Escalating Middle East Tensions
Trump Demands Iran's Unconditional Surrender Amid Escalating Conflict
Israeli Airstrike Targets Iranian State TV in Central Tehran
President Trump is leaving the G7 summit early and has ordered the National Security Council to the Situation Room
Netanyahu Signals Potential Regime Change in Iran
Analysts Warn Iran May Resort to Unconventional Warfare
Iranian Regime Faces Existential Threat Amid Conflict
Energy Infrastructure Becomes War Zone in Middle East
Iran Conducts Ballistic Missile Launches Amid Heightened Tensions with Israel
Iran Signals Openness to Nuclear Negotiations Amid Ongoing Regional Tensions
Shock Within Iran’s Leadership: Khamenei’s Failed Plan to Launch 1,000 Missiles Against Israel
UK Deploys Jets to Middle East Amid Rising Tensions
Exiled Iranian Prince Reza Pahlavi Urges Overthrow of Khamenei Regime
×